Clinical trial
Safety and Efficacy of Treating Refractory Cancers With the Litx™ System: Phase II Safety and Efficacy Study in Patients With Liver Metastases From Colorectal Cancer That Have Failed Chemotherapy
NCT00068068 is registered in ClinicalTrials.gov with Light Sciences LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Treating Refractory Cancers With the Litx™ System: Phase II Safety and Efficacy Study in Patients With Liver Metastases From Colorectal Cancer That Have Failed Chemotherapy
- Lead sponsor
- Light Sciences LLC
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2003
- Completion date
- Not reported
- Enrollment
- 25
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal neoplasms, liver metastasis, liver neoplasms, neoplasm metastasis